Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Clinical and Experimental Gastroenterology
|
February 17, 2023
Emerging Data on the Safety and Efficacy of Ripretinib for the Treatment of Gastrointestinal Stromal Tumors
Prapassorn Thirasastr, Neeta Somaiah
Therapeutic Advances in Medical Oncology
|
March 7, 2022
Overview of systemic therapy options in liposarcoma, with a focus on the activity of selinexor, a selective inhibitor of nuclear export in dedifferentiated liposarcoma
Prapassorn Thirasastr, Neeta Somaiah
Current Treatment Options in Oncology
|
February 28, 2023
Myxoid Liposarcomas: Systemic Treatment Options
Elise F Nassif, Emily Z Keung, Prapassorn Thirasastr, et al.
Surgical Oncology Clinics of North America
|
June 17, 2022
New Drug Approvals for Sarcoma in the Last 5 Years
Prapassorn Thirasastr, Mehdi Brahmi, Armelle Dufresne, et al.
Anticancer Research
|
December 8, 2019
Feasibility Technique of Low-passage <i>In Vitro</i> Drug Sensitivity Testing of Malignant Pleural Effusion from Advanced-stage Non-small Cell Lung Cancer for Prediction of Clinical Outcome
Chanida Vinayanuwattikun, Ornjira Prakhongcheep, Sucharat Tungsukruthai, et al.
Frontiers in Oncology
|
February 27, 2023
Case report: Responses to the combination of gemcitabine with sirolimus in two patients with <i>TSC</i>-mutated sarcomas
Elise F Nassif, Cissimol P Joseph, Rossana Lazcano, et al.
Cancer Research Communications
|
June 11, 2026
Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment
Homma M Khosroyani, Alina Teuber, Ajia Town, et al.
Cancer Medicine
|
September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma
Prapassorn Thirasastr, Heather Lin, Behrang Amini, et al.
Cell Reports. Medicine
|
February 18, 2026
Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancer
Zecheng Yang, Madelaine S Theardy, Shuaitong Chen, et al.
Cancers
|
March 13, 2024
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Clinical and Experimental Gastroenterology
|
February 17, 2023
Emerging Data on the Safety and Efficacy of Ripretinib for the Treatment of Gastrointestinal Stromal Tumors
Prapassorn Thirasastr, Neeta Somaiah
Therapeutic Advances in Medical Oncology
|
March 7, 2022
Overview of systemic therapy options in liposarcoma, with a focus on the activity of selinexor, a selective inhibitor of nuclear export in dedifferentiated liposarcoma
Prapassorn Thirasastr, Neeta Somaiah
Current Treatment Options in Oncology
|
February 28, 2023
Myxoid Liposarcomas: Systemic Treatment Options
Elise F Nassif, Emily Z Keung, Prapassorn Thirasastr, et al.
Surgical Oncology Clinics of North America
|
June 17, 2022
New Drug Approvals for Sarcoma in the Last 5 Years
Prapassorn Thirasastr, Mehdi Brahmi, Armelle Dufresne, et al.
Anticancer Research
|
December 8, 2019
Feasibility Technique of Low-passage <i>In Vitro</i> Drug Sensitivity Testing of Malignant Pleural Effusion from Advanced-stage Non-small Cell Lung Cancer for Prediction of Clinical Outcome
Chanida Vinayanuwattikun, Ornjira Prakhongcheep, Sucharat Tungsukruthai, et al.
Frontiers in Oncology
|
February 27, 2023
Case report: Responses to the combination of gemcitabine with sirolimus in two patients with <i>TSC</i>-mutated sarcomas
Elise F Nassif, Cissimol P Joseph, Rossana Lazcano, et al.
Cancer Research Communications
|
June 11, 2026
Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment
Homma M Khosroyani, Alina Teuber, Ajia Town, et al.
Cancer Medicine
|
September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma
Prapassorn Thirasastr, Heather Lin, Behrang Amini, et al.
Cell Reports. Medicine
|
February 18, 2026
Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancer
Zecheng Yang, Madelaine S Theardy, Shuaitong Chen, et al.
Cancers
|
March 13, 2024
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, et al.
Page
of 2